Thursday, October 4, 2012

Viking's Mistral Raymond Out Three Weeks With Foot Injury

Minnesota Vikings' starting strong safety Mistral Raymond dislocated his right ankle during the first quarter of last week's game against the San Francisco 49ers. Raymond was attempting to tackle 49ers halfback Frank Gore on the final play in the 24-13 win. He immediately summoned trainers and was writhing in pain before the medical staff immobilized his leg and transported him to the locker room. He was seen on crutches in the locker room after the game with the leg heavily wrapped.
A specialist determined that Raymond will not need surgery on his right injured ankle, and he should be expected to return to the line up in about a month. The Vikings' doctors think "maybe three to five week maybe before we'll get him back," said coach Leslie Frazier. "So we'll see how that goes. They confirmed that there was no need for surgery. So that was good news." That particular timeline would have Raymond returning after a Thursday night game against Tampa Bay on October 25th.
"Mentally, I'm in a much better place," said Raymond after the game. "Physically, it's about the same. Today is Day 1. Whenever they tell me it's all right to start working to get back to where I was, I'll be ready to go."
Raymond has not put up big numbers thus far in the season. He has five tackles and one defended pass over the first three games. Drafted in the sixth round of the 2011 draft, he put up 22 tackles, three defended passes, one fumble recovery, and one interception in 10 games in his rookie season. While Raymond is recovering, Jamarca Sanford will take his position, a position he lost to Raymond in training camp.
If you are a football player suffering from a foot injury, call our Newington, Kensington, or Middletown office to make an appointment.
Craig M. Kaufman, DPM
Connecticut Foot Care Centers
Sports Podiatrist in CT
Podiatrist in Newington, Kensington, and Middletown, CT
Visit our website, friend and like our page on Facebook, and follow my tweets on Twitter.

Enhanced by Zemanta

No comments:

Post a Comment